WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 5.3% of their position (10K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $4.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/28/2025ACC: 0001213900-25-048304
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+10K
Net shares
Net buyer
$4.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$0.43
Trade value
$4.33K
% of position
5.3%
5/27/2025
187.93K→197.93K
Total
Net shares
+10K
Net value
$4.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2025 | P · Purchase | +10K | $0.43 | $4.33K | 5.3% | 187.93K | 197.93K |
| Total | +10K | $4.33K | ||||||
Derivative Transactions0
No derivative transactions reported